Opinion

Dubai built something great in its healthcare sector. Now comes the real test.

Fifteen years ago, a GCC resident needing a complex cardiac procedure, spinal surgery, or a difficult cancer operation would, almost as a matter of reflex, book a flight to London, Houston or Bangkok. The assumption was that for any serious condition, you went abroad. The Gulf was for minor procedures; real medicine happened elsewhere.

That assumption has been slowly and systematically dismantled. Over the past decade and a half, Dubai and the wider GCC have invested heavily in building a healthcare system that can compete on the world stage, attracting elite surgeons, opening internationally accredited facilities, and convincing patients across the region that they no longer need to travel to receive world-class care. It has been one of the great success stories of the Gulf’s economic transformation.

That progress is now being tested. Regional anxiety, a cooling of international health tourism, demographic shifts in the expat population, and a wider economic squeeze are converging on a hospital sector that was already navigating profitability challenges before any of this began. The question for healthcare leaders across the Gulf right now is simple: do you manage this moment reactively, or do you use it to build something better?

A market already at an inflection point

Before external pressures arrived, Dubai’s private hospital market was already living with a structural tension. With 55 private hospitals and 68 specialised clinics serving the emirate, and bed occupancy rates running at around 50% across the UAE, the sector was operating close to the financial margins that most hospital administrators recognise as break-even territory.

That number matters because of what it tells you about revenue generation. Hospital profitability is not simply about filling beds – it is about what happens in those beds. The difference between a hospital running a busy maternity unit, a colonoscopy suite and an ENT ward, versus one with a high-performing cardiac surgery or complex orthopaedic programme, is enormous in financial terms. High-volume, lower-complexity work keeps the lights on. Complex, high-acuity surgery is what makes a hospital commercially viable and, frankly, clinically relevant.

This matters because the Gulf faces a particular structural challenge when it comes to surgical volumes. The GCC countries have relatively young and relatively small populations by global standards – and a surgeon’s skills are, in a very real sense, maintained by repetition. High-volume complex surgery requires a large enough patient pool to sustain it.  That has always been the constraint the region has been working to overcome. And over the past fifteen years, it had been making genuine progress.

When everything tightens at once

Several forces are now pressing on that progress simultaneously, and understanding how they interact is crucial.

First, inbound health tourism has slowed. The GCC medical tourism market had been growing at a compound annual rate of over 10% in the years to 2023, drawing patients from Africa, Asia and beyond to Dubai’s internationally accredited facilities. Regional uncertainty, the kind that puts people off booking flights, let alone elective surgery in a foreign city, has a direct impact on this pipeline. Patients who were considering travelling for procedures are either deferring or reconsidering entirely.

Second, movement in the expat population, including medical professionals, creates a simultaneous squeeze on both the demand and supply sides of the equation. This is not a new dynamic for the Gulf, where the healthcare system is heavily dependent on internationally trained staff. When external anxiety influences where skilled professionals choose to base themselves, the fragility of that dependency becomes visible very quickly.

Third – and this is the pressure that will play out most slowly but most significantly – the wider economic anxiety flowing through sectors such as aviation and hospitality creates a delayed but significant risk for health insurance funding. Dubai’s aviation sector alone accounted for 27% of the emirate’s GDP in 2023, supporting over 630,000 jobs. When industries of this scale face prolonged disruption, redundancies follow. And redundancies mean fewer people with employer-funded health insurance. The reduction in insured lives flows directly to hospitals, not immediately but with a months-long lag, which makes it easy to underestimate.

History gives us a useful, if uncomfortable, reference point. Periods of regional geopolitical stress have consistently demonstrated that healthcare systems in the Gulf are acutely sensitive to demographic shifts. When large expatriate communities, whether workers, business owners or families, reassess their commitment to a location, the effects ripple through every sector of the economy, including healthcare. The IMF has noted that the risk of prolonged regional conflict could reduce tourism, investment, and economic activity across the GCC. Healthcare is not immune to any of those pressures.

This is not the time to retreat

This is the part of the conversation that matters most, because there is always a risk that hospital leaders will respond to a period of reduced demand by making cuts that feel prudent but are, ultimately, self-defeating. Across the GCC, the sector has been moving towards what healthcare strategists call value-based care: organising services around quality of outcomes rather than volume of activity. A difficult period is exactly the wrong time to abandon that trajectory.

Rationalisation, done intelligently, is not the same as retreat. A hospital that consolidates around genuine centres of excellence, that says clearly, ‘we are exceptionally good at cardiac surgery, or complex orthopaedics, or neurology’, will emerge from a difficult period stronger. It will attract the cases that matter, generate the revenue it needs, and, crucially, retain the surgeons who came to the Gulf to practise high-end medicine, not to manage underutilised wards.

That last point, surgeon retention, is the single most urgent priority right now. The specialists who chose Dubai over a teaching hospital in Europe or a practice in North America made that decision for a combination of reasons: the quality of facilities, the opportunity to build a genuine surgical programme, the lifestyle, and the cases. Volume of complex cases, in particular, is not just a revenue driver – it is what keeps a surgeon at the top of their craft. A period of reduced elective demand, if poorly managed, risks triggering exactly the kind of talent attrition that would set back years of progress in a matter of months.

The UAE has already shown it understands this, at a policy level. The extension of Golden Visas to doctors and specialist medical professionals was a direct recognition that healthcare talent is a long-term national asset, not a transactional resource. The challenge now is to translate that policy instinct into operational decisions at the hospital level.

There is also a necessary conversation to be had between hospital operators and health insurers. The insurance funding model has been under strain even during the good times, and a contraction of the insured population will accelerate that strain. A race to the bottom on pricing, with hospitals discounting to fill beds and insurers tightening networks to control costs, would damage quality across the board. The more productive response involves a genuine collaborative effort to build sustainable pricing models that reward outcomes and support the investment in complex surgical capability that both parties ultimately need.

The Gulf has been here before

It is worth stepping back and looking at the broader context. The UAE has successfully navigated the 2008 global financial crisis, which struck Dubai’s economy hard and forced a fundamental rethink of its economic model. It has weathered sustained oil price shocks. It has come through the Covid pandemic, which crushed the aviation and tourism sectors that are the engine of Dubai’s economy, and rebounded to welcome more than 18.72 million international visitors in 2024, well above pre-pandemic levels.

Each of those moments of pressure was followed by structural reform and renewed growth. What distinguishes the UAE’s track record is not its avoidance of difficulty but its response to challenging times. Its approach has involved policy clarity and investment in long-term foundations rather than short-term contraction. The fundamentals that made Dubai a compelling regional healthcare hub – world-class infrastructure, an internationally accredited hospital network (the UAE has more JCI-accredited hospitals per capita than any other country), a regulatory environment that attracts talent, and unmatched geographic and logistical connectivity – remain intact.

The GCC’s young demographic profile is often cited as a challenge, and, for now, the pool of older patients needing complex surgery is relatively small. But the region is ageing, and with that comes a rapid increase in exactly the conditions that drive high-acuity surgical demand, such as cardiovascular disease, cancer, diabetes, and complex orthopaedic needs. Healthcare expenditure reflects this trajectory, projected to grow at a compound annual rate of nearly 8% through to 2029, reaching almost USD 160 billion. This is not a market in demographic decline – it is one in transition.

What happens next is a choice

What was built over the past fifteen years did not happen by accident. The talent pipeline, the surgical programmes, the institutional confidence that persuaded patients across the region to stop flying to London and start trusting Dubai all happened because of deliberate, sustained investment and because the right people chose to make this place their professional home.

That asset is worth protecting with the same intentionality. The decisions made in hospital boardrooms, by insurers, and at the policy level over the next twelve to eighteen months will determine whether the Gulf’s healthcare system emerges from this period as a more focused, more specialised, more resilient proposition, or loses ground that will take another decade to recover.

The case for treating healthcare infrastructure as strategic national capital, not just a commercial sector to be managed through a difficult quarter, has never been more compelling. The Gulf built something genuinely impressive. The task now is to ensure it comes through this period not just intact but sharpened.

Mark Adams

author
With over 40 years of experience in health insurance and clinical operations, Mark Adams began his career in insurance broking and dental capitation before transitioning to hospital and clinic management in the UK, US, and Middle East. Mark has run organisations including AXA Healthcare, Denplan, Virgin Healthcare, Gulf Healthcare, and Anglo Arabian Healthcare. Currently, Mark is CEO of Dubai’s leading 5-star hospital, the Clemenceau Medical Center. He also serves on the boards of Johns Hopkins Aramco Healthcare and Tibbiyah in Saudi Arabia. He is also the Chair of Renovo Healthcare, a UK Hospital Group. Mark has previously sat on the boards of the NMC Hospitals, the British Quality Foundation, the London Board of the NSPCC, and has run the leading social care charity Community Integrated Care where he was twice voted Healthcare Leader of the Year in the Charitable sector. He has also advised Prudential on entering the health insurance market and sat on the board of PruHealth (Vitality Healthcare) during the launch of this market challenger.